China Petroleum and others set up a joint exploration company in Xinjiang with a registered capital of 1 billion yuan. According to the enterprise search APP, PetroChina Tayou Joint Exploration (Xinjiang) Co., Ltd. was recently established, with the legal representative of Liu Weibo and a registered capital of 1 billion yuan. Its business scope includes: mineral resources exploration. Enterprise survey shows that the company is jointly owned by PetroChina Taihu (Beijing) Investment Co., Ltd., a wholly-owned subsidiary of China Petroleum, and Xinjiang Yaxin CBM Investment and Development (Group) Co., Ltd.Shanghai's state-owned assets reform index rose, with the daily limit of First Medicine, Yimin Group, Kaikai Industry and Shanghai Phoenix, and Shanghai 900 rose by more than 8%.Trump said that he chose Kari Lake as the director of VOA.
PETER LAMELAS was nominated by Trump as the US ambassador to Argentina.OPEC continues to lower its global oil demand forecast. According to Xinhua News Agency, the Organization of Petroleum Exporting Countries (OPEC) released its monthly oil market report on the 11th, lowering its global oil demand forecast for 2024 and 2025. This is the fifth time that OPEC has lowered its global oil demand forecast for this year and next since August this year.Baijiayun received $15 million in financing. One-stop AI video technology service provider Baijiayun (NASDAQ:RTC) announced that the company had signed a series of important agreements with YA II PN, Ltd, a fund managed by Yorkville Advisors Global and LP. The company received $15 million in financing, and the down payment of $3 million was received on the signing date of the agreement.
Genting Xinyao: The first prescription of itramod in Macau, China officially benefited Asian patients. Genting Xinyao announced that its first prescription of itramod was made in Jinghu Hospital in Macau, China on December 11th, which was the first prescription made by itramod after it was approved in Genting Xinyao Asia Authorized Zone, marking that this heavy product in the field of autoimmune diseases officially began to benefit Asian patients. Luo Yongqing, CEO of Genting Xinyao, said that the arrival of the first prescription of Ithmod in China and Macau was another milestone in the commercialization of Genting Xinyao. By 2030, the number of patients with ulcerative colitis in China is expected to more than double that in 2019, reaching about 1 million. There is a huge unmet demand for innovative therapies. Following the approval in Macau in April this year, Iturmod, as the third commercial new drug of Genting Xinyao, will bring new treatment options to more patients with ulcerative colitis.The turnover of Shanghai and Shenzhen stock markets exceeded 1 trillion for the 52nd consecutive trading day, exceeding 10 billion compared with yesterday.Xinwei launched the Intel Eagle Stream platform 4U8 card server P5500G5H. Recently, Xinwei launched the Intel Eagle Stream platform 4U8 card server P5500G5H, which has the characteristics of leading architecture, super computing power and flexible expansion, and provides strong computing support for different AI applications. Xinwei P5500G5H server can support running hundreds of billions of parameter models. In terms of framework and algorithm, it supports mainstream AI frameworks such as PyTorch, TensorFlow, caffe, mxnet and popular development tools such as DeepSpeed.
Strategy guide
12-13
Strategy guide 12-13
Strategy guide
Strategy guide
12-13
Strategy guide
Strategy guide 12-13
Strategy guide 12-13